Optegra, the specialist eye hospital group, has launched a series of peer review events to bring together optometrists for discussion on key conditions and eye health issues.
To run across the network of hospitals, the first meeting was launched at Optegra Surrey Eye Hospital, in Guildford, the brainchild of Leyana Martin, Optegra’s Professional Partnerships Manager. The two hour meetings welcome a group of optometrists to discuss a specific subject through interactive discussion, and optometrists gain three CET points for attending.
Attendees bring case studies with them which are relevant to the topic and are then discussed amongst the group. The group is led by one of Optegra’s ophthalmic consultants.
The first meeting was about glaucoma and was led by ophthalmic surgeon Michael Jeffrey, one of Optegra’s specialists in this field. The session specifically looked at different topical therapies, with further meetings planned on ‘OCT – Interpretation and Investigation’, and ‘The Cornea – when to treat and when to refer’.
Optegra’s Leyana Martin said: “The first Peer Review meeting was extremely well received, and we are creating a lot of interest amongst the optometrist community as they also receive their CET points. It has been such a success that we are due to launch them from some of our hospitals in the North as well, as well as from Optegra Solent Eye Hospital.”
Christopher Hall, Optometrist from C.E.Hall Optometrists Ltd. In Farnham, who attended the Peer Review meeting on glaucoma, said: “When I commenced practice the ophthalmologists rarely communicated with opticians and possibly our diagnostic skills were poor. Glaucoma, and the missing of the onset of the disease is probably every optometrist’s nightmare.
“It was good to work in a small group and discuss specific patients with the ophthalmologist, discussing how he would have treated the condition. Thanks to excellent mediation everybody was able to raise particular queries and thanks to consultant Mike Jeffrey’s advice two patients have now had altered treatment.”
For further information on the peer review meetings please contact Optegra on 0800 358 0825; or visit www.optregra.com.